Search results
Pharma CEOs are in wait-and-see mode on Mark Cuban's attempt to lower prices on generic drugs. 'It's...
Business Insider via Yahoo News· 1 year agoMark Cuban.Brian Snyder/Reuters The billionaire Mark Cuban wants to change the face of generic...
The generic drugs in you cabinet may have never been tested. That can't continue| Opinion
The Columbus Dispatch via Yahoo News· 2 years agoRosemary Gibson is author of "China Rx" and chairwoman of the Healthcare Committee for the Coalition...
$2 Generic Drugs Are on the Horizon
Verywell Health via Yahoo News· 1 year agoThe Centers for Medicare and Medicaid Services (CMS) is testing a new model that would let people on Medicare get many generic drugs for copayments of $2...
First it was blood pressure medication. Now FDA eyes more drugs for cancer-causing chemical.
USA TODAY via Yahoo News· 1 year agoFor people managing high blood pressure, recalls of the carcinogen-tainted drug quinapril might...
Pharma's expensive gaming of the drug patent system is successfully countered by the Medicines...
The Conversation via Yahoo News· 1 year agoDrug patents don't necessarily spur companies to innovate so much as restrict access to their IP....
Is prescription copay assistance contributing to rising drug prices? Why buyers should beware.
USA TODAY via Yahoo Finance· 2 years agoWhen Beth Waldron got a letter from her health insurance provider last year that her blood thinner...
Why Generic Drugs Aren’t Getting Cheaper for You
GOBankingRates via Yahoo Finance· 5 months agoOne of the common causes for people existing across the political aisle is the cost of prescription drugs. In fact, one study published by JAMA indicated...
Column: Everyone is thrilled that Medicare can finally negotiate drug prices. Prepare to be...
LA Times via Yahoo Finance· 2 years agoPresident Biden hands the pen used to sign the Inflation Reduction Act of 2022 to Sen. Joe Manchin...
Unveiling Viatris (VTRS)'s Value: Is It Really Priced Right? A Comprehensive Guide
GuruFocus.com via Yahoo Finance· 8 months agoViatris Inc (NASDAQ:VTRS) has seen a 3.5% daily gain, a 3-month gain of 4.33%, and an Earnings Per...
Mark Cuban’s next act on drug costs: Tackling insulin
NBC Universal via AOL· 1 year agoBillionaire entrepreneur Mark Cuban says it’s not a matter of if his online business will sell...
